Abivax SA
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Abivax SA and buy or sell other stocks, ETFs, and their options commission-free!About ABVX
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines.
CEOMarc M. P. de Garidel
CEOMarc M. P. de Garidel
Employees69
Employees69
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2013
Founded2013
Employees69
Employees69
ABVX Key Statistics
Market cap10.28B
Market cap10.28B
Price-Earnings ratio-44.01
Price-Earnings ratio-44.01
Dividend yield—
Dividend yield—
Average volume1.88M
Average volume1.88M
High today$134.74
High today$134.74
Low today$122.81
Low today$122.81
Open price$129.25
Open price$129.25
Volume1.59M
Volume1.59M
52 Week high$138.49
52 Week high$138.49
52 Week low$4.77
52 Week low$4.77
Stock Snapshot
With a market cap of 10.28B, Abivax SA(ABVX) trades at $125.14. The stock has a price-to-earnings ratio of -44.01.
On 2025-12-12, Abivax SA(ABVX) stock moved within a range of $122.81 to $134.74. With shares now at $125.14, the stock is trading +1.9% above its intraday low and -7.1% below the session's peak.
Trading activity shows a volume of 1.59M, compared to an average daily volume of 1.88M.
The stock's 52-week range extends from a low of $4.77 to a high of $138.49.
The stock's 52-week range extends from a low of $4.77 to a high of $138.49.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%